Nasdaq18d
FDA grants Sonoma 510(k) approval for Microdacyn Hydrogel
The FDA posted online 510(k) approval for Sonoma Pharmaceuticals (SNOA)’ Microdacyn Hydrogel, which is intended for use of acute and chronic wounds, ulcers, cuts, abrasions and burns healing.
FDA grants Sonoma 510(k) approval for Microdacyn Hydrogel
The FDA posted online 510(k) approval for Sonoma Pharmaceuticals (SNOA)’ Microdacyn Hydrogel, which is intended for use of acute and ...
Investing18d
Sonoma Pharmaceuticals gains FDA clearance for hydrogel
These are the recent developments at Sonoma Pharmaceuticals. Sonoma Pharmaceuticals' recent FDA clearance for Microdacyn® Hydrogel comes at a critical time for the company, as revealed by ...